Skip to main content
PREDILIFE logo

PREDILIFE — Investor Relations & Filings

Ticker · ALPRE ISIN · FR0010169920 LEI · 9695006IK5NBKHQU9116 PA Human health and social work activities
Open in API
Filings indexed 150 across all filing types
Latest filing 2023-04-27 Earnings Release
Country FR France
Listing PA ALPRE

About PREDILIFE

https://www.predilife.com/en/

PREDILIFE specializes in predictive medicine, developing solutions to assess an individual's risk of developing major diseases. The company's approach integrates medical data, such as genetic testing and imaging, with artificial intelligence and mathematical models to create personalized risk profiles. Its primary offerings are predictive health check-ups, including a specialized test for assessing the 5-year risk of breast cancer (MammoRisk®) and a multi-condition check-up that evaluates the risk for several common cancers (lung, prostate, colorectal, melanoma) and cardiovascular disease. Based on these risk profiles, PREDILIFE provides personalized follow-up and preventive recommendations. The company offers its end-to-end solution, which includes remote consultations, to businesses, insurers, and healthcare professionals to facilitate wider access to preventive care.

Recent filings

Filing Released Lang Actions
PREDILIFE: RÉSULTATS ANNUELS 2022 : PREDILIFE CONFIRME SA TRAJECTOIRE DE CROISSANCE ET ANNONCE UN DOUBLEMENT DE SON CHIFFRE D'AFFAIRES
Earnings Release Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and announces the "RÉSULTATS ANNUELS 2022" (Annual Results 2022). It provides key financial highlights (revenue, operating result, net result) for the year ended December 31, 2022, comparing them to 2021. This format, focusing on key figures and a brief management commentary immediately following the close of the fiscal year, strongly indicates an Earnings Release (ER). Although it mentions the full Annual Financial Report will be made available later, the document itself is the initial announcement of the results, fitting the definition of an Earnings Release (ER). The document length (4220 chars) is consistent with a summary release rather than the full 10-K. FY 2022
2023-04-27 French
PREDILIFE ACCOMPAGNE COLAS RAIL POUR PRENDRE SOIN DE SES COLLABORATRICES AVEC LE BILAN PRÉDICTIF DU CANCER DU SEIN
Environmental & Social Information Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) and is dated April 11, 2023. It announces a partnership between PREDILIFE and COLAS RAIL regarding a breast cancer predictive screening program. This type of announcement, detailing a business development, partnership, or general corporate news that doesn't fit a specific financial filing category (like 10-K, ER, or DIV), is best classified as a general Regulatory Filing or Regulatory Announcement. Since it is a press release announcing a business event rather than a formal regulatory filing like a 10-K or a specific financial result release (ER), and it doesn't fit other specific categories (like M&A, Capital Change, or Director Dealing), the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (2479 chars), which supports the idea that it is an announcement rather than a comprehensive report.
2023-04-11 French
PREDILIFE SELECTIONNÉE EN SUISSE POUR SON INNOVATION DÉDIÉE À LA SANTE DES FEMMES
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE" (Press Release) dated March 15, 2023. It announces that PREDILIFE has been selected for the Swiss FemTech program Tech4Eva. This is a general announcement regarding a business development/partnership opportunity, not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial event like a dividend (DIV) or capital change (CAP). Since it is a general corporate announcement that doesn't fit the highly specific categories (like M&A, Director Dealing, or Voting Results), it falls best under the general regulatory/corporate announcement category, which is RNS (Regulatory Filings) as the fallback for miscellaneous announcements.
2023-03-15 French
MISE À DISPOSITION DU DOCUMENT D'ENREGISTREMENT UNIVERSEL
Report Publication Announcement Classification · 1% confidence The document is very short (1762 characters) and explicitly announces the availability of a major report, the 'Document d'Enregistrement Universel' (Universal Registration Document), which was approved by the AMF. It states that this document 'peut être consulté sur le site Internet de la société' (can be consulted on the company's website) and mentions that it integrates financial statements for past periods. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report has been published or is available elsewhere classifies as a Report Publication Announcement (RPA), rather than the full report itself (which would likely be a 10-K or IR if comprehensive). The French term 'Mise à disposition du document' strongly suggests an announcement of availability.
2023-02-17 French
REPARTITION DU VOLUME DES VENTES 2022 : PRECISIONS COMPLEMENTAIRES AU COMMUNIQUE DU 04/01/2023
Earnings Release Classification · 1% confidence The document is a 'COMMUNIQUÉ DE PRESSE' (Press Release) dated January 31, 2023, providing 'PRECISIONS COMPLEMENTAIRES' (additional clarifications) regarding previously announced 2022 sales volumes. It details contract values, segmentation (sales via doctors vs. companies), and mentions that the final 2022 revenue ('chiffre d'affaires') will be communicated later after the analysis of services in progress is complete. This document is an update on financial performance metrics (sales volumes) but explicitly states that the final revenue figure is forthcoming. Since it is a press release providing key financial updates and clarifications, it aligns best with the 'Earnings Release' (ER) category, which covers initial announcements of periodical financial results (even if this is a clarification/update to an earlier announcement). It is too specific for a general 'Regulatory Filing' (RNS) and is not a full report (10-K or IR). Given the context of clarifying sales figures, ER is the most appropriate fit. FY 2022
2023-01-31 French
BILAN SEMESTRIEL AU 31/12/2022 DU CONTRAT DE LIQUIDITE PREDILIFE
Capital/Financing Update Classification · 1% confidence The document is titled "COMMUNIQUÉ DE PRESSE 18 JANVIER 2023" and specifically details the "BILAN SEMESTRIEL AU 31/12/2022 DU CONTRAT DE LIQUIDITE PREDILIFE" (Semi-annual report as of 12/31/2022 for the PREDILIFE liquidity contract). This document reports on the activity of a liquidity contract (share trading/cash balance) over the second half of 2022. This type of disclosure, which details transactions and balances related to market making or liquidity provision, is a specific regulatory disclosure, often related to share capital management or market transparency. It is not a full Annual Report (10-K), an Interim Report (IR), or a standard Earnings Release (ER). It is a specific regulatory announcement concerning share activity/market operations. Given the options, it most closely aligns with a specific regulatory filing or announcement that doesn't fit the major financial report categories. Since it details specific transactions and balances related to the company's shares/market presence, and it is a formal press release announcing a required periodic update, it fits best under the general 'Regulatory Filings' (RNS) category as a specific, non-standard disclosure, or potentially 'Transaction in Own Shares' (POS) if the focus was solely on repurchases, but the liquidity contract context makes RNS more appropriate as a catch-all for specific regulatory disclosures not covered elsewhere. Given the detailed transaction log, it is a specific regulatory disclosure, thus RNS is the most suitable fallback.
2023-01-18 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.